BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10779331)

  • 1. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo.
    Wang D; Russell JL; Johnson DG
    Mol Cell Biol; 2000 May; 20(10):3417-24. PubMed ID: 10779331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
    Pierce AM; Fisher SM; Conti CJ; Johnson DG
    Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.
    Wang D; Russell J; Xu H; Johnson DG
    Mol Carcinog; 2001 Jun; 31(2):90-100. PubMed ID: 11429786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activities of E2F family members: unique functions in regulating transcription.
    Pierce AM; Schneider-Broussard R; Philhower JL; Johnson DG
    Mol Carcinog; 1998 Jul; 22(3):190-8. PubMed ID: 9688145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.
    Pierce AM; Gimenez-Conti IB; Schneider-Broussard R; Martinez LA; Conti CJ; Johnson DG
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8858-63. PubMed ID: 9671769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite functions for E2F1 and E2F4 in human epidermal keratinocyte differentiation.
    Paramio JM; Segrelles C; Casanova ML; Jorcano JL
    J Biol Chem; 2000 Dec; 275(52):41219-26. PubMed ID: 11005809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myc lacks E2F1's ability to suppress skin carcinogenesis.
    Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
    Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
    Halaban R; Cheng E; Smicun Y; Germino J
    J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
    Nakajima Y
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular effects of E2F overexpression.
    Adams PD; Kaelin WG
    Curr Top Microbiol Immunol; 1996; 208():79-93. PubMed ID: 8575214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
    Jones SJ; Dicker AJ; Dahler AL; Saunders NA
    J Invest Dermatol; 1997 Aug; 109(2):187-93. PubMed ID: 9242506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model.
    Pierce AM; Schneider-Broussard R; Gimenez-Conti IB; Russell JL; Conti CJ; Johnson DG
    Mol Cell Biol; 1999 Sep; 19(9):6408-14. PubMed ID: 10454586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of loss of E2F1 on liver regeneration or hepatocarcinogenesis in C57BL/6J or C3H/HeJ mice.
    Lukas ER; Bartley SM; Graveel CR; Diaz ZM; Dyson N; Harlow E; Yamasaki L; Farnham PJ
    Mol Carcinog; 1999 Aug; 25(4):295-303. PubMed ID: 10449036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct capacities of individual E2Fs to induce cell cycle re-entry in postmitotic lens fiber cells of transgenic mice.
    Chen Q; Liang D; Yang T; Leone G; Overbeek PA
    Dev Neurosci; 2004; 26(5-6):435-45. PubMed ID: 15855772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
    Chen Q; Hung FC; Fromm L; Overbeek PA
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of BRCA1 expression by the Rb-E2F pathway.
    Wang A; Schneider-Broussard R; Kumar AP; MacLeod MC; Johnson DG
    J Biol Chem; 2000 Feb; 275(6):4532-6. PubMed ID: 10660629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y; Zacksenhaus E
    Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.